ScaleReady
John Wilson is the Founder and CEO of Wilson Wolf Manufacturing Corporation, a company focused on simplifying cell and gene therapy manufacturing. John also founded CellReady, a company aimed at accelerating the path to meaningful clinical data for cell and gene therapy companies. John is a Co-Founder and Board Member of Wilson Foundation Minnesota, which supports impactful organizations and programs. John is also a Co-Founder and Board of Director Member of ScaleReady, a joint venture dedicated to revolutionizing cell and gene therapy manufacturing. Previously, John was the Co-Founder, CEO, and Director of Marker Therapeutics, where they developed a manufacturing platform for T cell therapies. John also co-founded AlloVir, a public company that commercializes virus-specific T cell therapies.
John Wilson has a degree in Mechanical Engineering BS from the University of Minnesota. John also holds a Business Administration BA and an Economics BA from Hamline University. The specific start and end years for each degree are not provided.
This person is not in any teams
ScaleReady
ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf. Bringing together proven tools and technologies for cell culture, cell activation, gene editing, and cell processing, ScaleReady provides leading therapeutic developers with the most simple, scalable, and versatile manufacturing platform in the industry.